More about continuing management

Continuing management of patients at risk of MRONJ will largely be no different from the routine management of any other patient group.

Straightforward extractions and other bone impacting treatments can and should be carried out in primary care and the circumstances for seeking advice from a specialist are the same as for a patient not taking anti-resorptive or anti-angiogenic medication.

Due to the increasing incidence of bacterial resistance and the numerous side effects associated with antibiotic therapy, antibiotics should only be prescribed where there is clear evidence that patients will benefit from them.

There is currently insufficient evidence to support the use of antibiotic or topical antiseptic prophylaxis to reduce the risk of MRONJ following extractions or procedures that impact on bone.